Matthew D. Breyer

Matthew D. Breyer's AcademicInfluence.com Rankings

Matthew D. Breyer

Law

#2774

World Rank

#3446

Historical Rank

Common Law

#146

World Rank

#158

Historical Rank

law Degrees

Download Badge

Matthew D. Breyer's Degrees

PhD Biomedical Sciences Johns Hopkins University
Doctorate Medicine Harvard University

Why Is Matthew D. Breyer Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Matthew D. Breyer's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prostanoid receptors: subtypes and signaling. (2001) (1016)
Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. (1994) (903)
Mouse models of diabetic nephropathy. (2009) (853)
Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption (2005) (607)
Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney. Elucidation of signal transduction pathways. (1989) (424)
Salt–sensitive hypertension and reduced fertility in mice lacking the prostaglandin EP2 receptor (1999) (398)
Serial determination of glomerular filtration rate in conscious mice using FITC-inulin clearance. (2004) (323)
Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice. (2006) (322)
Physiological regulation of cyclooxygenase-2 in the kidney. (2001) (296)
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. (2001) (292)
Prostaglandin E receptors and the kidney. (2000) (291)
Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. (2002) (275)
Sirt1 activation protects the mouse renal medulla from oxidative injury. (2010) (274)
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. (2005) (273)
Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension (2001) (247)
Physiological regulation of prostaglandins in the kidney. (2008) (241)
G protein-coupled prostanoid receptors and the kidney. (2001) (231)
Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cyclooxygenase-2. (2001) (222)
Cyclooxygenase-2-selective inhibitors impair glomerulogenesis and renal cortical development. (2000) (202)
Long-term treatment of glucagon-like peptide-1 analog exendin-4 ameliorates diabetic nephropathy through improving metabolic anomalies in db/db mice. (2007) (196)
Conditional Knockout of Macrophage PPARγ Increases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor–Deficient Mice (2005) (190)
Utility of endogenous creatinine clearance as a measure of renal function in mice. (2004) (184)
PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. (2004) (178)
Deficiency of endothelial nitric-oxide synthase confers susceptibility to diabetic nephropathy in nephropathy-resistant inbred mice. (2007) (175)
The next generation of therapeutics for chronic kidney disease (2016) (175)
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. (1997) (174)
Expression of Peroxisome Proferator-Activated Receptor γ (PPARγ) in Human Transitional Bladder Cancer and its Role in Inducing Cell Death (1999) (170)
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice. Commentary (2006) (168)
Reduction of renal superoxide dismutase in progressive diabetic nephropathy. (2009) (161)
Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells. (1997) (161)
Functional and molecular aspects of renal prostaglandin receptors. (1996) (154)
Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. (2000) (150)
Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse). (2003) (147)
Dehydration activates an NF-kappaB-driven, COX2-dependent survival mechanism in renal medullary interstitial cells. (2000) (147)
Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells. (2003) (143)
Physiologic and pathophysiologic roles of lipid mediators in the kidney. (2007) (143)
Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. (2006) (142)
Prostaglandin E2 inhibits renal collecting duct Na+ absorption by activating the EP1 receptor. (1998) (138)
Circulating αKlotho influences phosphate handling by controlling FGF23 production. (2012) (138)
Cyclooxygenase 2 and the kidney (2001) (133)
Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. (2006) (133)
Prostaglandin E2-EP4 Receptor Promotes Endothelial Cell Migration via ERK Activation and Angiogenesis in Vivo* (2007) (129)
Hormonal signaling and regulation of salt and water transport in the collecting duct. (1994) (128)
Prostaglandin E2 inhibits sodium transport in rabbit cortical collecting duct by increasing intracellular calcium. (1991) (127)
PGE2 inhibits AVP-induced water flow in cortical collecting ducts by protein kinase C activation. (1990) (125)
Lithium treatment inhibits renal GSK-3 activity and promotes cyclooxygenase 2-dependent polyuria. (2005) (123)
Evidence that separate PGE2 receptors modulate water and sodium transport in rabbit cortical collecting duct. (1993) (123)
Differential expression of the intermediate filament protein nestin during renal development and its localization in adult podocytes. (2006) (118)
Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma. (2001) (116)
Upregulation of type I collagen by TGF-β in mesangial cells is blocked by PPARγ activation (2002) (110)
Differential localization of prostaglandin E receptor subtypes in human kidney. (1996) (107)
Mouse models of diabetic nephropathy. (2005) (107)
Peroxisome Proliferator-activated Receptor δ Activation Promotes Cell Survival following Hypertonic Stress* (2002) (105)
Prostaglandin receptors: their role in regulating renal function. (2000) (104)
Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting. (2007) (104)
Regulation of renal function by prostaglandin E receptors. (1998) (103)
Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival. (1999) (100)
Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. (2008) (96)
Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney* (1999) (96)
Prostaglandin E2-Mediated Attenuation of Mesocortical Dopaminergic Pathway Is Critical for Susceptibility to Repeated Social Defeat Stress in Mice (2012) (96)
Hypertonic Stress Activates Glycogen Synthase Kinase 3β-mediated Apoptosis of Renal Medullary Interstitial Cells, Suppressing an NFκB-driven Cyclooxygenase-2-dependent Survival Pathway* (2003) (93)
Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. (1994) (93)
Cyclooxygenase-2 expression is associated with the renal macula densa of patients with Bartter-like syndrome. (2000) (92)
PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice. (2006) (91)
Characterization of murine vasopressor and vasodepressor prostaglandin E(2) receptors. (2000) (91)
Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney. (2004) (87)
Differentiation of Cyclooxygenase 1- and 2–Derived Prostanoids in Mouse Kidney and Aorta (2006) (87)
Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid ω-1 Hydroxylase Predominantly Expressed in Brain* (2001) (86)
Generation of a conditional allele of the mouse prostaglandin EP4 receptor (2004) (84)
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. (1999) (82)
In situ hybridization and localization of mRNA for the rabbit prostaglandin EP3 receptor. (1993) (81)
Urogenital distribution of a mouse membrane-associated prostaglandin E(2) synthase. (2001) (78)
Segmental distribution of epidermal growth factor binding sites in rabbit nephron. (1990) (78)
Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. (1997) (77)
Overexpression of cyclooxygenase-2 predisposes to podocyte injury. (2007) (76)
Luminal prostaglandin E receptors regulate salt and water transport in rabbit cortical collecting duct. (1995) (76)
Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development. (2018) (75)
5,6-EET inhibits ion transport in collecting duct by stimulating endogenous prostaglandin synthesis. (1995) (71)
Epidermal growth factor inhibits the hydroosmotic effect of vasopressin in the isolated perfused rabbit cortical collecting tubule. (1988) (69)
COX2 Activity Promotes Organic Osmolyte Accumulation and Adaptation of Renal Medullary Interstitial Cells to Hypertonic Stress* (2003) (68)
Update on cyclooxygenase-2 inhibitors. (2006) (68)
Cloning and expression of the rabbit prostaglandin EP4 receptor. (1996) (67)
Peroxisome proliferator-activated receptor-γ activity is associated with renal microvasculature (2001) (66)
Expression and Molecular Pharmacology of the Mouse CRTH2 Receptor (2003) (66)
The Role of PPARs in the Transcriptional Control of Cellular Processes. (2002) (65)
Glycogen synthase kinase 3 inhibition improves insulin-stimulated glucose metabolism but not hypertension in high-fat-fed C57BL/6J mice (2007) (64)
A prospective study of multiple protein biomarkers to predict progression in diabetic chronic kidney disease. (2014) (64)
Peroxisome Proliferator–Activated Receptor α/γ Dual Agonist Tesaglitazar Attenuates Diabetic Nephropathy in db/db Mice (2007) (63)
Cytochrome P450 metabolites of arachidonic acid are potent inhibitors of vasopressin action on rabbit cortical collecting duct. (1989) (61)
A maladaptive role for EP4 receptors in podocytes. (2010) (60)
Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c. (2008) (58)
Diabetic nephropathy: of mice and men. (2005) (58)
Upregulation of type I collagen by TGF-beta in mesangial cells is blocked by PPARgamma activation. (2002) (57)
Phorbol myristate acetate, dioctanoylglycerol, and phosphatidic acid inhibit the hydroosmotic effect of vasopressin on rabbit cortical collecting tubule. (1987) (56)
Cellular mechanisms of prostaglandin E2 and vasopressin interactions in the collecting duct. (1990) (55)
Endothelin-1 receptor antagonist: effects on endothelin- and cyclosporine-treated mesangial cells. (1992) (54)
Liver X receptor-α mediates cholesterol efflux in glomerular mesangial cells (2004) (54)
Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule. (2006) (53)
Contribution of prostaglandin EP(2) receptors to renal microvascular reactivity in mice. (2002) (52)
Axial heterogeneity of vasopressin-receptor subtypes along the human and mouse collecting duct. (2007) (52)
Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice. (2016) (51)
Differential, inducible gene targeting in renal epithelia, vascular endothelium, and viscera of Mx1Cre mice. (2003) (50)
Inactivation of the E-Prostanoid 3 Receptor Attenuates the Angiotensin II Pressor Response via Decreasing Arterial Contractility (2012) (48)
Glomerular injury is exacerbated in diabetic integrin α1-null mice (2006) (48)
Apoptosis of the thick ascending limb results in acute kidney injury. (2008) (45)
Single amino acid substitution in aquaporin 11 causes renal failure. (2008) (45)
Expression of the prostaglandin F receptor (FP) gene along the mouse genitourinary tract. (2003) (44)
Better nephrology for mice--and man. (2010) (44)
Roles of lipid mediators in kidney injury. (2007) (43)
Developing Treatments for Chronic Kidney Disease in the 21st Century. (2016) (42)
Role of cytochrome P-450 epoxygenase metabolites in EGF signaling in renal proximal tubule. (1995) (42)
Anti sense DNA down-regulates proteins kinase C-epsilon and enhances vasopressin-stimulated Na+ absorption in rabbit cortical collecting duct. (1995) (42)
Structure‐Function Analyses of Eicosanoid Receptors: Physiologic and Therapeutic Implications (2000) (42)
Urine concentrating defect in prostaglandin EP1-deficient mice. (2007) (41)
Regulation of rabbit medullary collecting duct cell pH by basolateral Na+/H+ and Cl-/base exchange. (1989) (40)
Cyclooxygenase-2 selective inhibitors and the kidney. (2001) (40)
Feedback inhibition of cyclic adenosine monophosphate-stimulated Na+ transport in the rabbit cortical collecting duct via Na(+)-dependent basolateral Ca++ entry. (1991) (40)
EP1−/− Mice Have Enhanced Osteoblast Differentiation and Accelerated Fracture Repair (2010) (39)
Volume and agonist-induced regulation of myosin light-chain phosphorylation in glomerular mesangial cells. (1993) (38)
Effects of trifluoperazine, ouabain, and ethacrynic acid on intestinal calcium transport. (1983) (38)
PGE2 regulates cAMP production in cultured rabbit CCD cells: evidence for dual inhibitory mechanisms. (1992) (38)
Regulation of water and salt transport in collecting duct through calcium-dependent signaling mechanisms. (1991) (38)
Cyclooxygenase-1 Deficiency in Bone Marrow Cells Increases Early Atherosclerosis in Apolipoprotein E– and Low-Density Lipoprotein Receptor–Null Mice (2005) (37)
Cyclooxygenase-2–Dependent Prostacyclin Formation Is Regulated by Low Density Lipoprotein Cholesterol In Vitro (2002) (37)
Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. (2017) (36)
Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice. (2007) (35)
Peroxisome proliferator-activated receptor-gamma activity is associated with renal microvasculature. (2001) (34)
Expression of nestin in the podocytes of normal and diseased human kidneys. (2007) (33)
cAMP-dependent protein kinase mediates hydrosmotic effect of vasopressin in collecting duct. (1992) (33)
Glomerular injury is exacerbated in diabetic integrin alpha1-null mice. (2006) (33)
Mineralocorticoid regulation of cyclooxygenase-2 expression in rat renal medulla. (2002) (32)
Aberrant bispecific antibody pharmacokinetics linked to liver sinusoidal endothelium clearance mechanism in cynomolgus monkeys (2016) (32)
Characterization of a Rabbit Kidney Prostaglandin F2α Receptor Exhibiting Gi-restricted Signaling That Inhibits Water Absorption in the Collecting Duct* (2005) (31)
Functional characterization of alpha- and beta-intercalated cell types in rabbit cortical collecting duct. (1991) (30)
SOD1, but not SOD3, deficiency accelerates diabetic renal injury in C57BL/6-Ins2(Akita) diabetic mice. (2012) (30)
Generation and functional confirmation of a conditional null PPARγ allele in mice (2002) (30)
Epithelial COX-2 Expression Is Not Regulated By Nitric Oxide in Rodent Renal Cortex (2002) (29)
Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells. (2004) (29)
Effect of selective cyclooxygenase-2 (COX-2) inhibitor treatment on glucose-stimulated insulin secretion in C57BL/6 mice. (2007) (29)
Importance of the extracellular domain for prostaglandin EP(2) receptor function. (1999) (29)
Overcoming Barriers in Kidney Health-Forging a Platform for Innovation. (2016) (27)
Phorbol ester and A23187 have additive but mechanistically separate effects on vasopressin action in rabbit collecting tubule. (1988) (27)
Defective expression of Tamm-Horsfall protein/uromodulin in COX-2-deficient mice increases their susceptibility to urinary tract infections. (2005) (27)
Prostaglandin E-prostanoid-3 receptor activation of cyclic AMP response element-mediated gene transcription. (1999) (27)
Functional and molecular aspects of prostaglandin E receptors in the cortical collecting duct. (1995) (27)
Regulation of net bicarbonate transport in rabbit cortical collecting tubule by peritubular pH, carbon dioxide tension, and bicarbonate concentration. (1986) (26)
Cloning and expression of the rabbit prostaglandin EP2 receptor (2002) (26)
Expression of mouse membrane-associated prostaglandin E2 synthase-2 (mPGES-2) along the urogenital tract. (2006) (26)
Mouse EP3 α, β, and γ Receptor Variants Reduce Tumor Cell Proliferation and Tumorigenesis in Vivo* (2008) (26)
Molecular cloning and characterization of mouse CYP2J6, an unstable cytochrome P450 isoform. (2002) (25)
Measurement of glomerular filtration rate in conscious mice. (2009) (25)
Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies. (2022) (25)
Targeting VE-PTP phosphatase protects the kidney from diabetic injury (2019) (25)
Dose-dependent heterogenous actions of vasopressin in rabbit cortical collecting ducts. (1989) (24)
Diphtheria Immunity in Massachusetts—A Study of Three Urban Patient Populations (1984) (24)
Cardiovascular effects of selective COX-2 inhibition: is there a class effect? The International COX-2 Study Group. (2006) (23)
Prostaglandin E 2 inhibits renal collecting duct Na + absorption by activating the EP 1 receptor (1998) (22)
A sensitized screen of N-ethyl-N-nitrosourea-mutagenized mice identifies dominant mutants predisposed to diabetic nephropathy. (2007) (21)
Increased severity of renal impairment in nephritic mice lacking the EP1 receptor. (2006) (21)
Cytosolic acidification stimulates a calcium influx that activates Na(+)-H+ exchange in LLC-PK1. (1991) (21)
Generation of a Tenascin-C-CreER2 Knockin Mouse Line for Conditional DNA Recombination in Renal Medullary Interstitial Cells (2013) (20)
Enhanced pressor response to acute Ang II infusion in mice lacking membrane-associated prostaglandin E2 synthase-1 (2010) (19)
Peroxisome Proliferator-Activated Receptor-Alpha Deficiency Protects Aged Mice from Insulin Resistance Induced by High-Fat Diet (2007) (19)
Effects of global or targeted deletion of the EP4 receptor on the response of osteoblasts to prostaglandin in vitro and on bone histomorphometry in aged mice. (2009) (18)
Hypertension and cyclooxygenase-2 inhibitors: target: the renal medulla. (2004) (18)
Increased dietary sodium induces COX2 expression by activating NFκB in renal medullary interstitial cells (2014) (17)
Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E2 synthase gene (2003) (17)
Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models. (2017) (17)
Role of TGF-alpha in the progression of diabetic kidney disease. (2017) (17)
Meningorectal fistula as a cause of polymicrobial anaerobic meningitis. (1982) (16)
Muscarinic receptor activation inhibits AVP-induced water flow in rabbit cortical collecting ducts. (1991) (15)
COX2 selective NSAIDs and renal function: gain without pain? (1999) (15)
Inflammatory modulation and wound repair. (2003) (15)
ATP-inhibitable Cl- channel in apical membranes of cultured rabbit cortical collecting duct cells. (1993) (14)
Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: impaired responsiveness in heterozygotes. (2005) (14)
Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study (2015) (13)
Prostaglandin Receptors in the Kidney: A New Route for Intervention? (1998) (13)
Cyclooxygenase-2 selective inhibitors and the kidney (2001) (13)
ANIMAL MODELS OF DIABETIC COMPLICATIONS CONSORTIUM (U01 DK61018) (2004) (13)
Novel avenues for drug discovery in diabetic kidney disease (2018) (13)
Bradykinin B2 type receptor activation regulates fluid and electrolyte transport in the rabbit kidney (2005) (12)
Expression of Mediators of Renal Injury in the Remnant Kidney of ROP Mice Is Attenuated by Cyclooxygenase-2 Inhibition (2005) (12)
Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria (2020) (12)
Diabetic nephropathy: leveraging mouse genetics (2006) (12)
Generation and Activity of a Humanized Monoclonal Antibody That Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands Transforming Growth Factor-α and Epiregulin (2014) (12)
Drug discovery for diabetic nephropathy: trying the leap from mouse to man. (2012) (11)
Triple signal transduction model for the mechanism of PGE2 actions in rabbit cortical collecting duct. (1991) (11)
Mechanisms and regulation of renal H+ and HCO3- transport. (1987) (11)
Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal model. (2008) (11)
A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy (2017) (11)
Improving productivity of modern-day drug discovery (2014) (11)
From bench to patient: model systems in drug discovery (2015) (10)
Viral transduction of renin rapidly establishes persistent hypertension in diverse murine strains. (2015) (10)
Arachidonic Acid Metabolites and the Kidney (2011) (10)
Targeted gene disruption of the prostaglandin E2 EP2 receptor. (2002) (9)
Diabetic nephropathy: a national dialogue. (2013) (9)
Characterization of diabetic nephropathy in a transgenic model of hypoinsulinemic diabetes. (2006) (8)
Induction of rabbit cyclooxygenase 2 in the anterior uvea following glaucoma filtration surgery. (1997) (8)
Insight into the genetics of diabetic nephropathy through the study of mice (2008) (8)
Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease (2019) (8)
Phosphatidates inhibit vasopressin-induced water transport via protein kinase C activation. (1989) (7)
Genetics of diabetic nephropathy: lessons from mice. (2007) (7)
Generation of a conditional allele for the mouse endothelial nitric oxide synthase gene (2012) (7)
Prostanoid receptors and the urogenital tract. (2003) (7)
Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E(2) synthase gene. (2003) (6)
Mechanism and regulation of proton transport in the outer medullary collecting duct. (1991) (6)
Evidence for basolateral membrane Ca2+/H+ exchange in outer medullary collecting duct. (1993) (5)
Pathological and Transcriptome Changes in the ReninAAV db/db uNx Model of Advanced Diabetic Kidney Disease Exhibit Features of Human Disease (2018) (5)
Expression of a novel sodium-hydrogen exchanger in the gastrointestinal tract and kidney (1995) (5)
Examining diabetic nephropathy through the lens of mouse genetics (2007) (5)
Diabetic nephropathy: introduction. (2007) (5)
Renal Medullary Interstitial Cells (2007) (5)
Getting to the heart of COX-2 inhibition. (2005) (5)
Osteopontin in diabetic nephropathy: signpost or road? (2010) (5)
Effect of vasopressin on intracellular Na+ concentration in cortical collecting duct. (1996) (4)
Progress in progression? (2010) (4)
Translating experimental diabetic nephropathy studies from mice to men. (2011) (3)
Characterization of the Proton‐Secreting Cell of the Rabbit Medullary Collecting Duct (1989) (3)
Targeted gene disruption of the prostaglandin E2 EP2 receptor (1999) (3)
Markers of Glycemic Control in the Mouse: Comparisons of Six- (2008) (3)
prostaglandin EP3 receptor (1993) (3)
Diabetic nephropathy: big and bad. (2005) (3)
Intrarenal distribution of rabbit PKC zeta. (1997) (3)
The Use of Genomics To Drive Kidney Disease Drug Discovery and Development. (2020) (3)
Faculty Opinions recommendation of Recruitment of podocytes from glomerular parietal epithelial cells. (2009) (2)
Structure and localization of the rabbit prostaglandin EP3 receptor. (1997) (1)
Abstract 5439: Metabolomic study of EGFR drug resistance mechanisms (2014) (1)
Eicosanoids and Renal Function (2013) (1)
Cyclooxygenase-2 contributes to diabetic nephropathy through glomerular EP4 receptor. (2022) (1)
Cloning and expression of the rabbit prostaglandin EP 2 receptor (2015) (1)
Molecular Stratification of Chronic Kidney Disease (2021) (1)
Generation and Activity of a Humanized Monoclonal Antibody that Selectively Neutralizes the Epidermal Growth Factor Receptor Ligands TGF-alpha and Epiregulin (2014) (1)
Glycogen Synthase Kinase 3 Inhibition Improves Insulin Stimulated Glucose Metabolismin High Fat Fed C57/BL6J Mice (2007) (1)
Beyond cyclooxygenase. (2002) (1)
Type II cAMP-dependent protein kinase regulates electrogenic ion transport in rabbit collecting duct. (1999) (1)
Erratum. Profibrotic Circulating Proteins and Risk of Early Progressive Renal Decline in Patients With Type 2 Diabetes With and Without Albuminuria. Diabetes Care 2020;43:2760–2767 (2020) (1)
Faculty Opinions recommendation of In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria. (2010) (0)
Induction of ABCA1 Expression by Liver X Receptor (LXR) agonist in Renal Glomerular Mesangial Cells (2006) (0)
Sirtuin‐1‐dependent COX2 Induction is an Essential Survival Mechanism in Renal Medullary Interstitial Cells against Oxidative Stress (2009) (0)
The Role of Prostaglandin EP1 and FP Receptors in the Regulation of Blood Pressure (2006) (0)
Faculty Opinions recommendation of Activated signal transduction kinases frequently occupy target genes. (2006) (0)
Faculty Opinions recommendation of Association of trypanolytic ApoL1 variants with kidney disease in African Americans. (2010) (0)
FP266GROWTH DIFFERENTIATION FACTOR 15 IS A NOVEL BIOMARKER FOR PREDICTION OF RENAL OUTCOMES IN CHRONIC KIDNEY DISEASE (2015) (0)
Faculty Opinions recommendation of A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes. (2014) (0)
Peroxisome proliferator-activated receptor γ (PPARγ) activity is associated with the renal microvasculature (2001) (0)
Liver X receptor (LXR) agonist TO‐901317 restores renal fatty acid synthase (FAS) expression in db/db mice (2007) (0)
Faculty Opinions recommendation of Blood pressure influences end-stage renal disease of Cd151 knockout mice. (2012) (0)
Review for "Improving Residual Risk of Renal and Cardiovascular Outcomes in Diabetic Kidney Disease: Review of Pathophysiology, Mechanisms and Evidence from Recent Trials" (2021) (0)
Abstract MP16: ReninAAV Uninephrectomized db/db Mice as a Novel Diabetic Kidney Diesease Model for Testing New Therapeutics on Top of RAS Inhibition (2015) (0)
Cyclooxygenase-2 regulates renal medullary blood flow and urinary sodium excretion (2001) (0)
DMM023036 1171..1174 (2015) (0)
Increased dietary sodium induces COX2 expression by activating NFκB in renal medullary interstitial cells (2013) (0)
Faculty Opinions recommendation of Evidence for hormonal control of heart regenerative capacity during endothermy acquisition. (2019) (0)
in urinary tract of rabbits and humans Expression of peroxisome proliferator-activated receptors (2016) (0)
Faculty Opinions recommendation of The natriuretic peptide/guanylyl cyclase--a system functions as a stress-responsive regulator of angiogenesis in mice. (2009) (0)
Profibrotic circulating proteins and risk of early progressive renal decline in Type 2 Diabetes patients with and without albuminuria (2020) (0)
Selective targeting of cyclooxygenase-2 reveals its role in renal medullary interstitial cell survival. (1999) (0)
Abstract 1866: Stable isotope resolved metabolomics of colorectal cancer cells treated with inhibitor of monocarboxylate transporter-1. (2013) (0)
Faculty Opinions recommendation of Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function. (2006) (0)
Faculty Opinions recommendation of Prolactin alters blood pressure by modulating the activity of endothelial nitric oxide synthase. (2016) (0)
Tackling AKI. (2023) (0)
Mitochondrial and NAD+ metabolism predict recovery from acute kidney injury in a diverse mouse population (2023) (0)
expression in rat renal medulla Mineralocorticoid regulation of cyclooxygenase-2 (2016) (0)
Regulation of Potassium Excretion in FP Knockout Mice (2007) (0)
Does Malfunction of Arachidonic Acid Epoxygenase Explain Salt-Sensitive Hypertension?: Salt-Sensitive Hypertension Is Associated with Dysfunctional Cyp4a10 Gene and Kidney Epithelial Sodium Channel. J Clin Invest 116: 1696-1702, 2006. (2006) (0)
Faculty Opinions recommendation of Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip. (2017) (0)
Faculty Opinions recommendation of Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. (2007) (0)
1654PNSCLC patient immune cell profiling and response of tumor antigen specific CD8 T cells to checkpoint receptor antagonists (2017) (0)
Type II cAMP-dependent protein kinase regulates electrogenic ion transport in rabbit collecting duct. (1999) (0)
Chapter 22 – Diabetic Nephropathy (2008) (0)
Faculty Opinions recommendation of Interaction between Epithelial Sodium Channel γ-Subunit and Claudin-8 Modulates Paracellular Sodium Permeability in Renal Collecting Duct. (2020) (0)
fibrates are used in this setting, renal function should be Drs. Broeders and Abramowicz made the clinically im- closely monitored. portant point that administration of fibrates to patients (2001) (0)
High Sodium Diet Activated NFκB Signaling Plays an Important Role in Renal Medullary COX2 Induction (2009) (0)
invited review Prostaglandin E receptors and the kidney (2000) (0)
A Novel Aldosterone Antagonist Limits Renal Injury in 5/6 Nephrectomy (2017) (0)
mice Mx1Cre vascular endothelium, and viscera of Differential, inducible gene targeting in renal epithelia, (2016) (0)
Clinical Trials in Diabetic Kidney Disease: Opportunities and Obstacles (2015) (0)
Faculty Opinions recommendation of CD4+CD25+ regulatory T cells attenuate cisplatin-induced nephrotoxicity in mice. (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Matthew D. Breyer?

Matthew D. Breyer is affiliated with the following schools:

Indiana University Bloomington
Indiana University
Kanazawa University
University of Ottawa
University of Michigan
Vanderbilt University
Stanford University
Johns Hopkins University
William & Mary
Harvard University